Abstract: Background: Cervical cancer is one of the main reasons for gynaecological cancer death that occurs worldwide.
Introduction
Cancer of the cervix is rated as the fourth most common cancer and cancer deaths among the female population in (2012), an estimation was (528,000) new patients of cervical cancer with (266,000) deaths. The majority of burden accounting for about (85%) has occurred in the less developed countries of the total cases of cervical cancer [1] .
Since the prescence and common use of the Pap test, which helps in the early detection of precancerous cervical lesions at an early stage, and the incidence of cancer of the cervix was dramatically decreased from (32/100.000) female in the (1940s) to (8.3/100.000)female in the (1980s). Yet, in many parts of developing countries, there is still risk of cervical cancer, which cause significant morbidity and mortality [2] .
Cervical cancer starts with abnormal changes in the cervical cellular lining or surface. Typically, these changes usually occur in the cervical squamous-columnar junction. Here, cylindrical secretory epithelial cells (columnar) meet the protective flat epithelial cells (squamous) from the outer cervix and vagina in what is termed the transformation zone. The continuous replacement of columnar epithelial cells by squamous epithelial cells in this area makes these cells vulnerable to take up foreign or abnormal genetic material [3] .
Cervical cancer screening is very effective because of the presence of a precursor lesion, cervical intraepithelial neoplasia (CIN), helps determine whether there is a need for further tests. Over a long period lesions start as dysplasia and progress in a predictable process, allowing a great opportunity for intervention at a precancerous stage [4] .
Cervical cancer screening must beginning at (25) years of age every three years. The interval is extended to every five years for women's age more than (50) years. The women aged (65) years or more, they should screen only when they haven't screened since their age was (50) years, or when they have an abnormality of a recent result of the test [5] .
The screenings of cervical cancer in many developing countries are not available or are poorly accessible. Cervical cancer knowledge among female population is still limited and thus women are less willing to receive cervical cancer screening. Educational levels and misconceptions may also contribute to the poor uptake of cervical cancer screening [6] .
The disease diagnosis based not only on a Pap test. Cervical cancer can be diagnosed with a biopsy from tissue. When found an abnormality result of a Pap test should perform a colposcopy and cervical biopsy. When found a visible lesions should also perform a biopsy. When found an abnormality result from the physical examination may perform an ultrasound or computed tomography (CT) to confirm the results and determine the disease extend of invasion [7] . 
Methods
Cross-sectional (descriptive analytic) study was done among married women. The study was performed between October 2016 and February 2017 in Baghdad maternity hospitals. Non probability (purposive sample) used to collect the data from (400) married women who attained outpatient clinics in maternity hospitals. A questionnaire constructed by the researchers to identify women's practices about cervical cancer and screening. A pilot study conducted in order to determine the reliability of the questionnaire in a sample of (20) women who excluded from the study sample (r1= 0.96). Content validity was determined through a panel of (17) experts their experience mean and SD was 28.82 7.5. The data were collected after obtaining the agreement from women to participate in this study. The study instrument was consisted of two parts which include: Socio demographic characteristics, women's practices toward cervical cancer and screening. Data are analyzed through the use of SPSS (Statistical Process for Social Sciences) version 20 and excel.
Results
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Discussion
This study shows that the study population practices was poor and that could be due to the deficit of cervical cancer knowledge. In developed countries the level of knowledge was found to be high. Knowing cervical cancer risk factors is very important that can make women to avoid them, which leads to the prevention of cervical cancer. These results are consistent and supported by Bansal who found that the majority of respondents (90.5%) had never screened with the Pap smear test [9] . Shrestha who stated that the uptake of Pap smear test was only (10.5%) in their respondents [10] . Amarin who mentioned that the most of the study population (85.7%) hadn't uptake Pap smear and (14.3%) had received the Pap smear test [11] . Sait who found that only (16.8%) had undergone the test in their study population [12] . John who showed that only (14.2%) had ever been screened with a Pap smear test [13] . Al Sairafi & Mohamed who reported that the Pap smear test among studied women only (35.2%) [14] .
These results are inconsistent with the studies done by Cerigo who found that the majority of the study population (96%) had received a Pap smear [15] . Uysal & Birsel who reported that more than two thirds of their respondents (68.5%) screened with Pap smear test, about one third (31.5 %) of them hadn't screen [16] .
Regarding the reasons of didn't have Pap smear test the higher percentage of participants (65.8%) were "don't know", also approximately quarter of study sample (25.8%) were answered with "not necessary" while the lowest percentage (0.2%) of them were "fear".
These results are consistent and supported with the studies conducted by Bansal who demonstrated that more than two thirds of women (65%) were unaware of the cervical screening test [9] . John who showed that one third of the study population (30.7%) the barrier was lack of knowledge [13] . Amarin who reported that inadequate knowledge toward the screening was the major barriers to Pap smear screening [11] . Sait who stated that the lack of awareness was the main reason for didn't have a Pap smear test [12] .
The study results show that there were statistical significant differences between the practices and duration of marriage, while there were no statistical significant relationships between women's practices and (age, educational level, occupation status, and monthly income).
Shrestha and colleagues who stated that there were statistical significant relationships between Pap smear test and duration of marriage, for those who had been married for more than (20) years [10] . These results are inconsistent with Al Sairafi & Mohamed who showed that there were statistical significant relationships between Pap smear test and socio demographic variable, which include adequate practice towards the test was significantly associated with age of the women ( p= 0.022) between (30-49) years, age at first marriage (p = 0.031) ,also the duration of the last doctor visit (p= 0.016). Bansal, et.al. (2015) found that age, income, and marital status were independent predictors of Pap smear test practice [9] . Uysal and Birsel who reported that the percent of receiving cervical screening is high among age groups between (26-33), married women, secondary school education, urban area, medium and high income status, positive family history of the disease, and those previously informed of cervical cancer [16] .
Conclusion
This study revealed that women's practices concerning cervical cancer was poor. There are statistical significant differences between cervical screening practices and duration of marriage, while there are no statistical significant differences between women's practices with the left over study variable
Recommendation
It is important to design a booklet or pamphlet about cervical cancer risk factors, signs and symptoms, screening, and prevention to reach for all women over the country in order to decrease the morbidity and mortality rate of cervical cancer.
Encouraging the married women to take responsibility for their own health and be active participants in the cervical cancer screening program regularly, and eliminate barriers to cervical cancer screening to detect the precancerous cervical lesion and provide early treatment that will prevent the disease. 
